For the quarter ending 2025-09-30, SINT had $1,930K increase in cash & cash equivalents over the period. -$2,601K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -3,539 | -4,610 |
| Depreciation expense | 74 | 171 |
| Impairment of armor | 0 | 64 |
| Amortization of right of use asset | 77 | 169 |
| Loss on disposal of subsidiary | 0 | 25 |
| Amortization of intangible assets | 8 | 3 |
| Stock based compensation - employee | 546 | 193 |
| Stock based compensation - non-employee | 342 | 264 |
| Change in fair value of derivative liabilities | -214 | 48 |
| Bad debt (recoveries) expense | 2 | -3 |
| Loss (gain) on disposal of equipment | 0 | 352 |
| Trade accounts receivable | 25 | -12 |
| Prepaid expenses and other current assets | -200 | 130 |
| Inventories | 43 | -153 |
| Accounts payable and accrued liabilities | 464 | -217 |
| Other liabilities | -750 | 784 |
| Payments on operating lease liability | -87 | -188 |
| Net cash used in operating activities | -2,517 | -3,710 |
| Purchase of property and equipment | 84 | 59 |
| Proceeds from acquisition of sinaptic surgical | 750 | - |
| Proceeds from notes receivable, net of imputed interest | - | 0 |
| Proceeds from sale of property and equipment | 0 | 352 |
| Disposal of property and equipment, net of cash received | 0 | 4 |
| Proceeds from issuance of warrant derivative liabilities | - | 0 |
| Net cash provided by (used in) investing activities | 666 | 289 |
| Proceeds from issuance of common stock and prefunded warrants, net of cash fees | 1 | 4,379 |
| Proceeds from exercise of warrants, net of cash fees, and deposit for stock issuance (in other current liabilities) | 3,624 | - |
| Purchase of common stock into treasury | 0 | 133 |
| Proceeds from issuance of warrants in connection with exercise of warrants | 206 | - |
| Proceeds from issuance of common stock in connection with exercise of warrants | - | 0 |
| Payments on debt | 50 | 103 |
| Net cash provided by financing activities | 3,781 | 4,143 |
| Net increase in cash and cash equivalents | 1,930 | 722 |
| Cash and cash equivalents at beginning of period | 3,598 | - |
| Cash and cash equivalents at end of period | 6,250 | - |
Sintx Technologies, Inc. (SINT)
Sintx Technologies, Inc. (SINT)